title: Involvement of central serotonergic pathways in analgesia elicited by salmon calcitonin in the mouse.
abstract: The contribution of central serotonergic pathways to the analgesic activity induced by salmon calcitonin in the writhing test was investigated. Salmon calcitonin was administered to mice after lesioning of the ascending and descending serotonergic pathways by means of i.p. administration of p-chloroamphetamine (40 mg/kg, for 2 days) or p-chlorophenylalanine (300 mg/kg, for 3 days). The analgesic effect induced by salmon calcitonin at the doses of 10 and 20 IU/kg was not evident in mice previously treated with p-chloroamphetamine or p-chlorophenylalanine. However, the analgesic effect of salmon calcitonin 40 IU/kg was not significantly modified by p-chloroamphetamine or p-chlorophenylalanine pretreatment. Salmon calcitonin did not alter the depletion of 5-hydroxytryptamine (5-HT) and 5-hydroxyindoleacetic acid after p-chloroamphetamine or p-chlorophenylalanine administration. Similarly, this hormone did not change the NSD 1015-induced accumulation of 5-hydroxytryptophan or the tranylcypromine-induced accumulation of 5-HT. These results indicate that although salmon calcitonin does not influence the synthesis and metabolism of 5-HT, it does require the integrity of the serotonergic system in order to cause analgesia.
authors.affiliation: Departamento de Farmacología, Facultad de Medicina, Universidad Complutense, Madrid, Spain.
authors.forename: M I
authors.initials: MI
authors.lastname: Colado
authors.forename: M J
authors.initials: MJ
authors.lastname: Ormazabal
authors.forename: C
authors.initials: C
authors.lastname: Goicoechea
authors.forename: F
authors.initials: F
authors.lastname: Lopez
authors.forename: M J
authors.initials: MJ
authors.lastname: Alfaro
authors.forename: M I
authors.initials: MI
authors.lastname: Martin
mesh_terms: D000700:Analgesics / Q000494:pharmacology*; D000818:Animals; D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D001921:Brain / Q000187:drug effects* / Q000378:metabolism; D002116:Calcitonin / Q000494:pharmacology*; D010134:Fenclonine / Q000494:pharmacology; D006834:Hydrazines / Q000494:pharmacology; D006897:Hydroxyindoleacetic Acid / Q000378:metabolism; D007274:Injections, Intraperitoneal; D008297:Male; D051379:Mice; D010147:Pain Measurement; D012701:Serotonin / Q000378:metabolism*; D013116:Spinal Cord / Q000187:drug effects / Q000378:metabolism; D010133:p-Chloroamphetamine / Q000494:pharmacology
chemical_list: D000700:Analgesics; D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D006834:Hydrazines; D012701:Serotonin; D006897:Hydroxyindoleacetic Acid; D010133:p-Chloroamphetamine; C028815:salmon calcitonin; D002116:Calcitonin; C004297:3-hydroxybenzylhydrazine; D010134:Fenclonine